These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9342497)

  • 1. Sodium ferric gluconate and iron requirements in hemodialysis patients.
    Navarro JF; Teruel JL
    Clin Nephrol; 1997 Sep; 48(3):202. PubMed ID: 9342497
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
    Rodríguez Palomares JR; Fanlo B; Albarracín C; Junquera E
    Nefrologia; 2003; 23(2):181-2. PubMed ID: 12778887
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium ferric gluconate therapy in renal transplant and renal failure patients.
    Yorgin PD; Belson A; Sarwal M; Alexander SR
    Pediatr Nephrol; 2000 Dec; 15(3-4):171-5. PubMed ID: 11149105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of sodium ferric gluconate complex in haemodialysis patients has been extensively evaluated.
    Michael B
    Nephrol Dial Transplant; 2005 Aug; 20(8):1770. PubMed ID: 15956060
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron indices after administration of sodium ferric gluconate complex in hemodialysis patients.
    Shalansky K; Hanko J; Pudek M; Li G; Jastrzebski J
    Am J Kidney Dis; 2011 Oct; 58(4):684-5. PubMed ID: 21840100
    [No Abstract]   [Full Text] [Related]  

  • 6. Addressing patient concerns about intravenous iron therapy.
    Robbins KC
    Nephrol Nurs J; 2003 Apr; 30(2):220-4, 258. PubMed ID: 12737000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium ferric gluconate complex given intravenously for iron deficiency in hemodialysis.
    Pascual J; Teruel JL; Liaño F; Sureda A; Ortuño J
    Clin Nephrol; 1991 Feb; 35(2):87. PubMed ID: 2019020
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron absorption and utilization in maintenance hemodialysis patients: oral and intravenous routes.
    Magana L; Dhar SK; Smith EC; Martinez C
    Mt Sinai J Med; 1984 Apr; 51(2):180-3. PubMed ID: 6610116
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous iron-gluconate during haemodialysis modifies plasma beta2-microglobulin properties and levels.
    Michelis R; Sela S; Kristal B
    Nephrol Dial Transplant; 2005 Sep; 20(9):1963-9. PubMed ID: 15956071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
    Warady BA; Seligman PA; Dahl NV
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1140-6. PubMed ID: 17942782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron management: innovative solutions to persistent challenges--focus on Ferrlecit.
    Vogel S; Schweitzer S; Seiler S
    ANNA J; 1999 Oct; 26(5):515-21. PubMed ID: 10776080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with intravenous iron and ferritin level].
    Fernández-Gallego J; Martín MA; Sujan S; Vega E
    Nefrologia; 2010; 30(3):371-2. PubMed ID: 20514109
    [No Abstract]   [Full Text] [Related]  

  • 13. Do we need to change our administration practice with regard to sodium ferric gluconate complex in glucose?
    Bhowmik D; Tiwari SC
    Nephrol Dial Transplant; 2005 Jun; 20(6):1279. PubMed ID: 15797892
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
    Barbieri C; Bolzoni E; Mari F; Cattinelli I; Bellocchio F; Martin JD; Amato C; Stopper A; Gatti E; Macdougall IC; Stuard S; Canaud B
    PLoS One; 2016; 11(3):e0148938. PubMed ID: 26939055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis.
    Umanath K; Sika M; Niecestro R; Connelly C; Schulman G; Koury MJ; Lewis JB; Dwyer JP;
    Hemodial Int; 2013 Jan; 17(1):67-74. PubMed ID: 22702490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ferrokinetics in patients with chronic renal failure in hemodialysis].
    Miguel Carrasco A; Alcocer Ferrer H; Giner Segui R; Lozano Roig L; Caridad Monforte A; Romero de Avila C; Moreno Frigols J; Rosalen Archer R
    Rev Clin Esp; 1979 Apr; 153(2):113-5. PubMed ID: 482674
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hemodialysis on intestinal iron absorption in chronic kidney insufficiency].
    Patyna WD; Koch KM; Werner E
    Verh Dtsch Ges Inn Med; 1974; 80():681-4. PubMed ID: 4454635
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic iron in hemodialysis patients.
    Fishbane S; Miyawaki N; Masani N
    Kidney Int; 2004 Oct; 66(4):1714-5. PubMed ID: 15458478
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.
    Rostoker G; Griuncelli M; Loridon C; Couprie R; Benmaadi A; Bounhiol C; Roy M; Machado G; Janklewicz P; Drahi G; Dahan H; Cohen Y
    Am J Med; 2012 Oct; 125(10):991-999.e1. PubMed ID: 22998881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iron metabolism in patients in kidney failure dialysis treatment].
    Zadrazil J; Bachleda P; Papajík T; Scudla V; Zahálková J; Budíková M; Novotný D
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():95-7. PubMed ID: 7976690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.